The good press just keeps on coming "as a superior performing diagnostic for the earlier detection of ovarian cancer in symptomatic women".
Note the word "superior", another article mentioned "market leader".
Some good bids in early. These prices will be a distant memory if this product takes off like the reviews suggest
interesting article from us cancer site, page-10
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
